Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Virtual screening, identification and in vitro testing of novel inhibitors of O-acetyl-L-serine sulfhydrylase of Entamoeba histolytica.

Nagpal I, Raj I, Subbarao N, Gourinath S.

PLoS One. 2012;7(2):e30305. doi: 10.1371/journal.pone.0030305. Epub 2012 Feb 15.

2.

Inhibitors of Escherichia coli serine acetyltransferase block proliferation of Entamoeba histolytica trophozoites.

Agarwal SM, Jain R, Bhattacharya A, Azam A.

Int J Parasitol. 2008 Feb;38(2):137-41. Epub 2007 Oct 5.

PMID:
17991467
3.

Pyrazolo[3,4-d]pyrimidines as novel inhibitors of O-acetyl-L-serine sulfhydrylase of Entamoeba histolytica: an in silico study.

Yadava U, Shukla BK, Roychoudhury M, Kumar D.

J Mol Model. 2015 Apr;21(4):96. doi: 10.1007/s00894-015-2631-3. Epub 2015 Mar 25.

PMID:
25799964
4.

Metronidazole hydrazone conjugates: Design, synthesis, antiamoebic and molecular docking studies.

Ansari MF, Siddiqui SM, Agarwal SM, Vikramdeo KS, Mondal N, Azam A.

Bioorg Med Chem Lett. 2015 Sep 1;25(17):3545-9. doi: 10.1016/j.bmcl.2015.06.091. Epub 2015 Jul 3.

PMID:
26174554
5.
6.

Benzotriazoles and indazoles are scaffolds with biological activity against Entamoeba histolytica.

López-Vallejo F, Castillo R, Yépez-Mulia L, Medina-Franco JL.

J Biomol Screen. 2011 Sep;16(8):862-8. doi: 10.1177/1087057111414902. Epub 2011 Aug 5.

PMID:
21821786
7.

Synthesis, characterization, antiamoebic activity and toxicity of novel bisdioxazole derivatives.

Iqbal PF, Parveen H, Bhat AR, Hayat F, Azam A.

Eur J Med Chem. 2009 Nov;44(11):4747-51. doi: 10.1016/j.ejmech.2009.06.016. Epub 2009 Jun 21.

PMID:
19589625
8.

Functional correlation of medicinal chemistry and Entamoeba histolytica treatment: an emphasis on the past, present and future chemotherapy.

Gundamaraju R, Singla RK, Vemuri RC, Sekaran SD.

Mini Rev Med Chem. 2015;15(3):211-9. Review.

PMID:
25769970
9.

Molecular modeling on pyruvate phosphate dikinase of Entamoeba histolytica and in silico virtual screening for novel inhibitors.

Stephen P, Vijayan R, Bhat A, Subbarao N, Bamezai RN.

J Comput Aided Mol Des. 2008 Sep;22(9):647-60. Epub 2007 Aug 21.

PMID:
17710553
10.

Energy production in Entamoeba histolytica: new perspectives in rational drug design.

Saavedra-Lira E, Pérez-Montfort R.

Arch Med Res. 1996 Autumn;27(3):257-64. Review.

PMID:
8854380
11.

Entamoeba histolytica: identification of thioredoxin-targeted proteins and analysis of serine acetyltransferase-1 as a prototype example.

Schlosser S, Leitsch D, Duchêne M.

Biochem J. 2013 Apr 15;451(2):277-88. doi: 10.1042/BJ20121798.

PMID:
23398389
12.

Synthesis, characterization, antiamoebic activity and cytotoxicity of novel series of pyrazoline derivatives bearing quinoline tail.

Hayat F, Salahuddin A, Umar S, Azam A.

Eur J Med Chem. 2010 Oct;45(10):4669-75. doi: 10.1016/j.ejmech.2010.07.028. Epub 2010 Jul 23.

PMID:
20696501
13.

Single residue mutation in active site of serine acetyltransferase isoform 3 from Entamoeba histolytica assists in partial regaining of feedback inhibition by cysteine.

Kumar S, Mazumder M, Dharavath S, Gourinath S.

PLoS One. 2013;8(2):e55932. doi: 10.1371/journal.pone.0055932. Epub 2013 Feb 21.

14.

Structural and biochemical studies of serine acetyltransferase reveal why the parasite Entamoeba histolytica cannot form a cysteine synthase complex.

Kumar S, Raj I, Nagpal I, Subbarao N, Gourinath S.

J Biol Chem. 2011 Apr 8;286(14):12533-41. doi: 10.1074/jbc.M110.197376. Epub 2011 Feb 5.

15.

Drug resistance in amoebiasis.

Bansal D, Malla N, Mahajan RC.

Indian J Med Res. 2006 Feb;123(2):115-8. Review.

PMID:
16575108
16.

Synthesis and antiamoebic activity of 3,7-dimethyl-pyrazolo[3,4-e][1,2,4] triazin-4-yl thiosemicarbazide derivatives.

Singh S, Husain K, Athar F, Azam A.

Eur J Pharm Sci. 2005 Jun;25(2-3):255-62. Epub 2005 Apr 1.

PMID:
15911221
17.

Cytotoxic effect of amide derivatives of trifluoromethionine against the enteric protozoan parasite Entamoeba histolytica.

Sato D, Kobayashi S, Yasui H, Shibata N, Toru T, Yamamoto M, Tokoro G, Ali V, Soga T, Takeuchi T, Suematsu M, Nozaki T.

Int J Antimicrob Agents. 2010 Jan;35(1):56-61. doi: 10.1016/j.ijantimicag.2009.08.016. Epub 2009 Nov 12. Erratum in: Int J Antimicrob Agents. 2010 Apr;35(4):417.

PMID:
19910163
18.

Probing the antiamoebic and cytotoxicity potency of novel tetrazole and triazine derivatives.

Wani MY, Bhat AR, Azam A, Choi I, Athar F.

Eur J Med Chem. 2012 Feb;48:313-20. doi: 10.1016/j.ejmech.2011.12.033. Epub 2011 Dec 30.

PMID:
22236470
19.

Discovery of Entamoeba histolytica hexokinase 1 inhibitors through homology modeling and virtual screening.

Saucedo-Mendiola ML, Salas-Pacheco JM, Nájera H, Rojo-Domínguez A, Yépez-Mulia L, Avitia-Domínguez C, Téllez-Valencia A.

J Enzyme Inhib Med Chem. 2014 Jun;29(3):325-32. doi: 10.3109/14756366.2013.779265. Epub 2013 Mar 27.

PMID:
23534932
20.

Experimental amoebiasis and the development of anti-amoebic compounds.

Neal RA.

Parasitology. 1983 Feb;86 (Pt 1):175-91. Review. No abstract available.

PMID:
6300739

Supplemental Content

Support Center